Brazil ANVISA New Rule: Chinese Feed Additives Need GMP + AMR Reports

Brazil’s National Health Surveillance Agency (ANVISA) has introduced new import requirements for feed additives manufactured in China, effective 1 October 2026. The regulation directly impacts Chinese producers and exporters of probiotics, enzyme preparations, and organic acids — key segments in the animal health and feed additives supply chain.

Event Overview

On 21 April 2026, ANVISA published Resolution RDC No. 45/2026, amending import requirements for feed additives. Effective 1 October 2026, all such products imported into Brazil must be accompanied by two mandatory documents: (1) a Good Manufacturing Practice (GMP) certificate issued by China’s Ministry of Agriculture and Rural Affairs, and (2) original microbial antimicrobial resistance (AMR) monitoring data covering six consecutive months. The compliance window for affected Chinese enterprises is five months from publication.

Which Subsectors Are Affected

Direct Exporters (Chinese Animal Health & Feed Additive Manufacturers)
These companies face immediate documentation and procedural adjustments. The requirement to submit both a government-issued GMP certificate and raw AMR monitoring data — not summaries or third-party reports — introduces new validation and traceability expectations. Delays in obtaining either document may halt shipments post-1 October 2026.

Contract Manufacturers & OEM Suppliers
Firms producing under private label or contract for Brazilian or multinational buyers must now ensure their own facilities meet the GMP certification standard and maintain compliant AMR monitoring protocols — even if they do not hold brand ownership. Their capacity to provide auditable, month-by-month AMR records becomes a contractual prerequisite.

Import Agents & Distributors in Brazil
These intermediaries bear operational risk: incomplete or non-compliant documentation will trigger customs rejection or ANVISA review. They must now verify upstream documentation authenticity before shipment — including cross-checking GMP certificate issuance dates and confirming AMR data covers exactly six consecutive months prior to export.

Supply Chain Compliance & Certification Service Providers
Entities offering GMP guidance, regulatory filing support, or laboratory coordination for AMR testing may see increased demand. However, their role remains advisory — only China’s Ministry of Agriculture and Rural Affairs can issue the required GMP certificate, and only the manufacturer can generate first-hand AMR monitoring data.

What Enterprises Should Focus On Now

Confirm GMP Certificate Eligibility and Issuance Timeline

Verify whether current GMP certification (if held) meets ANVISA’s specific format and scope requirements under RDC No. 45/2026. Note that not all existing Chinese GMP certificates are automatically valid for Brazilian import purposes — some may require reissuance or endorsement. Initiate formal application with China’s Ministry of Agriculture and Rural Affairs without delay, as processing times are unconfirmed.

Establish and Document Six-Month AMR Monitoring Protocol

Begin AMR monitoring immediately if not already in place — using standardized methods aligned with internationally recognized frameworks (e.g., CLSI or EUCAST). Record raw data per batch or production cycle, including isolate identification, antimicrobial agents tested, inhibition zone diameters or MIC values, and strain source. Avoid retrospective reconstruction; ANVISA requires contemporaneous records.

Review Export Documentation Workflows

Map current export documentation processes to identify gaps: e.g., whether AMR data is currently collected, stored, translated, or certified for international submission. Assign internal responsibility (e.g., QA/QC or regulatory affairs) to manage dual-document preparation and ensure alignment between GMP validity periods and AMR reporting windows.

Engage Brazilian Import Partners Early

Share the regulatory timeline and documentation requirements with Brazilian import agents or buyers. Jointly confirm how documents will be transmitted (e.g., original hard copies, authenticated digital files), accepted formats (e.g., bilingual notarization), and contingency plans for discrepancies — especially given the absence of transitional provisions in RDC No. 45/2026.

Editorial Perspective / Industry Observation

From an industry perspective, this requirement reflects a broader tightening of sanitary and phytosanitary (SPS) controls on agricultural inputs in major import markets — particularly where antimicrobial stewardship is a policy priority. ANVISA’s mandate for raw, longitudinal AMR data — rather than pass/fail test results — signals a shift toward process-based oversight, emphasizing ongoing surveillance capability over point-in-time compliance.

Analysis来看, this is less a standalone technical update and more a structural signal: it aligns Brazil’s feed additive regulation with its human pharmaceutical and food safety frameworks, suggesting future harmonization across ANVISA-regulated product categories. It also underscores growing reliance on upstream manufacturing transparency — where documentation originates matters as much as what it states.

Current observation suggests the rule is already in force as law (published and dated), but practical enforcement readiness — including ANVISA’s capacity to validate foreign AMR datasets — remains to be observed. Therefore, while the legal deadline is fixed, operational interpretation may evolve through early implementation cases.

This regulation marks a material step in regulatory convergence between China’s domestic animal health standards and Brazil’s import requirements. Its significance lies not only in added documentation burden, but in the implicit expectation that Chinese manufacturers maintain continuous, auditable quality and resistance monitoring systems — extending beyond factory walls into microbiological practice. For stakeholders, it is best understood not as a one-time compliance task, but as an indicator of escalating global expectations for traceability, transparency, and scientific rigor in animal nutrition supply chains.

Source: ANVISA Resolution RDC No. 45/2026, published 21 April 2026; effective 1 October 2026. Official text available via ANVISA’s Diário Oficial da União portal. Note: Implementation guidance, acceptable AMR methodology standards, and GMP certificate formatting specifications are pending official clarification and remain under observation.